Last update:

One-time gene editing treatment lowers 'bad' cholesterol by up to 62%

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, as part of a study involving UCL scientists.

How aging reshapes sensorimotor learning: Older adults may lose explicit strategy but gain implicit adaptation

When most humans reach late adulthood, their ability to coordinate movements and maintain balance, broadly referred to as motor control, tends to gradually decline. While these changes in motor control are widely documented, ...

Medical research news

New T-cell engager shows promise for advanced solid tumors

As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a so-called bispecific T-cell ...

Why some chikungunya virus infections may turn chronic

Chikungunya virus, which is transmitted to people by infected Aedes mosquitoes and characterized by high fever and intense joint swelling and pain, has made a resurgence in many countries around the world in recent years.